Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metyrapone as Add-on Treatment in Major Depression
2007-000137-19Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metyrapone in major depressive disorder (MDD), sponsored by Leiden University Medical Center. Primary endpoint: Change in MADRS score at 5 weeks. Started Mar 2007; status: active.
02
Drugs
metyrapone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2007-000137-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000137-19.